Apollon Wealth Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1764387
MOUNT PLEASANT, SC
Position in ALNY
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$253,777
New position
Shares Held
767
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Apollon Wealth Management, LLC holds $22,162,227 across 13 Biotechnology names. ALNY ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,595 | $17,234,211 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,831 | $2,959,983 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,339 | $500,006 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
7,807 | $371,378 | |
| 5 | MRNA |
Moderna, Inc.
|
6,842 | $347,573 | |
| 6 | HURA |
TuHURA Biosciences, Inc./NV
|
158,010 | $282,837 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
767 | $253,777 | |
| 8 | FLNA |
Filana Therapeutics, Inc.
|
35,053 | $59,239 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $253,777 | 767 | Shares | Sole | 2026-04-22 | |
| No filing history on record for this holder in this stock. | ||||||